MolNFT v1 · #158955 · protein
KIRBAC3.1 at a resolution of 2 ångströms
6O9U · Inward rectifier potassium channel KIRBAC3.1: “KIRBAC3.1 at a resolution of 2 ångströms”. X-ray diffraction, 6 ligands (TMO, PCW, Z3P), 2 pockets (best druggability 0.33). MolNFT v1 #158955 on GenesisL1: 3D structure, binding sites…
- PDB
- 6O9U
- Type
- protein
- Length
- 283 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Inward rectifier potassium channel KIRBAC3.1
- UniProt
- D9N164
- Ligands
- TMO, PCW, Z3P, K, BA, CL
- Pockets
- 2 · best druggability 0.33
Structure
x-ray diffraction · 1 distinct chain · 31% helix, 32% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Inward rectifier potassium channel KIRBAC3.1 | protein | 283 | 31% helix, 32% strand | D9N164 |
Ligands and binding sites
- TMO · trimethylamine oxide · ligand · 3 copies · chains A
- PCW · 1,2-dioleoyl-sn-glycero-3-phosphocholine · ligand · 2 copies · chains A
- Z3P · 3,3',3''-phosphoryltripropanoic acid · ligand · chains A
- K · Potassium ion · metal · 9 copies · chains A
- BA · Barium ion · metal · chains A
- CL · Chloride ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 83 | 0.33 | 0.73 | 13 | empty |
| 2 | 52 | 0.26 | 0.73 | 16 | PCW |
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt D9N164
- Elsewhere: RCSB PDB 6O9U · PDBe 6O9U · UniProt D9N164
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.